GENSAIC, INC.
Biotech · Private
Phage-derived particle (PDP) gene delivery vectors engineered for tissue-specific in vivo gene therapy
- Grants
- $335K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 0 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Bioengineering of phage-derived particles as a discovery platform for muscle gene therapy | $334,571 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2910 | MEDCHEM PARTNERS LLC | — | — |
| 2911 | Percev LLC | — | — |
| 2912 | Aiolos Bio | — | — |
| 2913 | GENSAIC, INC. | — | — |
| 2914 | TRUCODE GENE REPAIR, INC. | — | — |
| 2915 | Sermonix Pharmaceuticals, Inc. | — | $43M |
| 2916 | VACCINEX, INC. | — | $44M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions For Targeted Delivery To Muscle Tissueapplication
- Compositions For Targeted Delivery To Adipose Tissueapplication
- Compositions For Targeted Delivery To Muscle Tissueapplication
- Compositions For Targeted Delivery To Muscle Tissueapplication
- Compositions For Targeted Delivery To Adipose Tissueapplication
- Icosahedral Phage Derived Particlesapplication
- Therapeutic Phage-derived Particlesapplication
- Icosahedral Phage Derived Particlesapplication
- Phage Derived Particles For Treatment Of Renal, Respiratory, And Gastrointestinal Disordersapplication
- Phage Derived Particles For Treatment Of Neurological And Age-related Disordersapplication
- Phage Derived Particles For Treatment Of Endocrine And Metabolic Disordersapplication
- Phage Derived Particles For Treatment Of Musculoskeletal Disordersapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.